ImmunoPrecise Antibodies (OTCMKTS:IPATF) Shares Up 0.7%

ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATFGet Rating)’s stock price shot up 0.7% on Wednesday . The company traded as high as $2.92 and last traded at $2.84. 10,218 shares traded hands during trading, a decline of 50% from the average session volume of 20,327 shares. The stock had previously closed at $2.82.

ImmunoPrecise Antibodies Price Performance

The company’s 50 day moving average is $2.85.

About ImmunoPrecise Antibodies

(Get Rating)

ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization.

Read More

Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with's FREE daily email newsletter.